QR kód

Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort

Objective. Data from trials demonstrated that abatacept (ABA) has a good safety and efficacy profile in treating rheumatoid arthritis. We have studied the retention rate of ABA in a real-life cohort of patients with rheumatoid arthritis. Methods. This is a monocentric, retrospective study includi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: E. Molteni, C. Pirone, F. Ceccarelli, C. Castellani, C. Alessandri, M. Di Franco, V. Riccieri, F.R. Spinelli, R. Priori, R. Scrivo, F. Conti
Médium: Artigo
Jazyk:Inglês
Vydáno: PAGEPress Publications 2024-06-01
Edice:Reumatismo
Témata:
On-line přístup:https://www.reumatismo.org/reuma/article/view/1608
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!